Retailers Can Split Claims In Loestrin Antitrust Trial
A group of retailers that bought the hormonal birth control pill Loestrin will be allowed to split their claims from the rest of the direct purchaser class in the upcoming trial...To view the full article, register now.
Already a subscriber? Click here to view full article